Indapamide - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for indapamide and what is the scope of patent protection?

Indapamide is the generic ingredient in two branded drugs marketed by Actavis Elizabeth, Ani Pharms, Aurobindo Pharma Usa, Chartwell Rx, Rising, Teva, Watson Labs, and Sanofi Aventis Us, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for indapamide. Seven suppliers are listed for this compound.

Summary for indapamide

US Patents:	0
Tradenames:	2
Applicants:	8
NDAs:	10
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	114
Clinical Trials:	32
Patent Applications:	6,546
Drug Prices:	Drug price trends for indapamide
What excipients (inactive ingredients) are in indapamide?	indapamide excipients list
DailyMed Link:	indapamide at DailyMed

See drug prices for indapamide

Recent Clinical Trials for indapamide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Bern	Phase 2
Insel Gruppe AG, University Hospital Bern	Phase 2
Centre for Chronic Disease Control, India	Phase 4

See all indapamide clinical trials

Pharmacology for indapamide

Drug Class	Thiazide-like Diuretic
Physiological Effect	Increased Diuresis

Medical Subject Heading (MeSH) Categories for indapamide

Antihypertensive Agents
Diuretics
Sodium Chloride Symporter Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for indapamide

C03BA	Sulfonamides, plain
C03B	LOW-CEILING DIURETICS, EXCL. THIAZIDES
C03	DIURETICS
C	Cardiovascular system

US Patents and Regulatory Information for indapamide

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rising	INDAPAMIDE	indapamide	TABLET;ORAL	074461-002	Mar 26, 1997	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Rx	INDAPAMIDE	indapamide	TABLET;ORAL	074594-002	May 23, 1996		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva	INDAPAMIDE	indapamide	TABLET;ORAL	074665-001	Apr 4, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for indapamide

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sanofi Aventis Us	LOZOL	indapamide	TABLET;ORAL	018538-001	Jul 6, 1983	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.